Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Journal for Equity in Health
Published in: International Journal for Equity in Health 1/2013

Open Access 01-12-2013 | Research

The influence of socio-economic status and multimorbidity patterns on healthcare costs: a six-year follow-up under a universal healthcare system

Authors: Raymond N Kuo, Mei-Shu Lai

Published in: International Journal for Equity in Health | Issue 1/2013

Login to get access

Abstract

Introduction

Multimorbidity has been linked to elevated healthcare utilization and previous studies have found that socioeconomic status is an important factor associated with multimorbidity. Nonetheless, little is known regarding the impact of multimorbidity and socioeconomic status on healthcare costs and whether inequities in healthcare exist between socioeconomic classes within a universal healthcare system.

Methods

This longitudinal study employed the claims database of the National Health Insurance of Taiwan (959 990 enrolees), adopting medication-based Rx-defined morbidity groups (Rx-MG) as a measurement of multimorbidity. Mixed linear models were used to estimate the effects of multimorbidity and socioeconomic characteristics on annual healthcare costs between 2005 and 2010.

Results

The distribution of Rx-MGs and total costs presented statistically significant differences among gender, age groups, occupation, and income class (p < .001). Nearly 80% of the enrolees were classified as multimorbid and low income earners presented the highest prevalence of multimorbidity. After controlling for age and gender, increases in the number of Rx-MG assignments were associated with higher total healthcare costs. After controlling for the effects of Rx-MG assignment and demographic characteristics, physicians, paramedical personnel, and public servant were found to generate higher total costs than typical employees/self-employed enrolees, while low-income earners generated lower costs. High income levels were also found to be associated with lower total costs. It was also revealed that occupation and multimorbidity have a moderating effect on healthcare cost.

Conclusions

Increases in the prevalence of multimorbidity are associated with higher health care costs. This study determined that instances of multimorbidity varied according to socioeconomic class; likewise there were inequities in healthcare utilization among individuals of various occupations and income levels, even when demographic characteristics and multimorbidity were controlled for. This highlights the importance of socioeconomic status with regard to healthcare utilization. These results indicate that socioeconomic factors should not be discounted when discussing the utilization of healthcare by patients with multimorbidity.
Literature
1.
Wong A, Boshuizen HC, Schellevis FG, Kommer GJ, Polder JJ: Longitudinal administrative data can be used to examine multimorbidity, provided false discoveries are controlled for. J Clin Epidemiol. 2011, 64: 1109-1117. 10.1016/j.jclinepi.2010.12.011.CrossRefPubMed
2.
Marengoni A, Winblad B, Karp A, Fratiglioni L: Prevalence of chronic diseases and multimorbidity among the elderly population in Sweden. Am J Public Health. 2008, 98: 1198-1200. 10.2105/AJPH.2007.121137.PubMedCentralCrossRefPubMed
3.
Starfield B, Kinder K: Multimorbidity and its measurement. Health Policy. 2011, 103: 3-8. 10.1016/j.healthpol.2011.09.004.CrossRefPubMed
4.
Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, Meinow B, Fratiglioni L: Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev. 2011, 10: 430-439. 10.1016/j.arr.2011.03.003.CrossRefPubMed
5.
Glynn LG, Valderas JM, Healy P, Burke E, Newell J, Gillespie P, Murphy AW: The prevalence of multimorbidity in primary care and its effect on health care utilization and cost. Fam Pract. 2011, 28: 516-523. 10.1093/fampra/cmr013.CrossRefPubMed
6.
7.
Wolff JL, Starfield B, Anderson G: Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med. 2002, 162: 2269-2276. 10.1001/archinte.162.20.2269.CrossRefPubMed
8.
Droomers M, Westert GP: Do lower socioeconomic groups use more health services, because they suffer from more illnesses?. European J Public Health. 2004, 14: 311-313. 10.1093/eurpub/14.3.311.CrossRef
9.
Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B: Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012, 380: 37-43. 10.1016/S0140-6736(12)60240-2.CrossRefPubMed
10.
11.
Schäfer I, Hansen H, Schon G, Hofels S, Altiner A, Dahlhaus A, Gensichen J, Riedel-Heller S, Weyerer S, Blank WA: The influence of age, gender and socio-economic status on multimorbidity patterns in primary care. first results from the multicare cohort study. BMC Heal Serv Res. 2012, 12:
12.
Agborsangaya CB, Lau D, Lahtinen M, Cooke T, Johnson JA: Multimorbidity prevalence and patterns across socioeconomic determinants: a cross-sectional survey. BMC Publ Health. 2012, 12:
13.
14.
15.
Whitehead M: The concepts and principles of equity and health. Int J Heal Serv. 1992, 22: 429-445. 10.2190/986L-LHQ6-2VTE-YRRN.CrossRef
16.
Forrest CB, Lemke KW, Bodycombe DP, Weiner JP: Medication, diagnostic, and cost information as predictors of high-risk patients in need of care management. Am J Managed Care. 2009, 15: 41-48.
17.
Starfield B, Weiner J, Mumford L, Steinwachs D: Ambulatory care groups - a categorization of diagnoses for research and management. Heal Serv Res. 1991, 26: 53-74.
18.
Tucker A, Weiner J, Abrams C: Health-based risk adjustment: application to premium development and profiling. Financial strategy for managed care organizations: rate setting, risk adjustment, and competitive advantage. Edited by: Wrightson CW. 2002, Chicago: Ill: Health Administration Press, 165-225.
19.
Kuo RN, Lai MS: Comparison of Rx-defined morbidity groups and diagnosis- based risk adjusters for predicting healthcare costs in Taiwan. BMC Health Serv Res. 2010, 10: 126-10.1186/1472-6963-10-126.PubMedCentralCrossRefPubMed
20.
Zhao Y, Ash AS, Ellis RP, Ayanian JZ, Pope GC, Bowen B, Weyuker L: Predicting pharmacy costs and other medical costs using diagnoses and drug claims. Medical Care. 2005, 43: 34-43.PubMed
21.
Farley JF, Harley CR, Devine JW: A comparison of comorbidity measurements to predict healthcare expenditures. Am J Managed Care. 2006, 12: 110-117.
22.
Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ: Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol. 2001, 154: 854-864. 10.1093/aje/154.9.854.CrossRefPubMed
23.
Perkins AJ, Kroenke K, Unutzer J, Katon W, Williams JW, Hope C, Callahan CM: Common comorbidity scales were similar in their ability to predict health care costs and mortality. J Clin Epidemiol. 2004, 57: 1040-1048. 10.1016/j.jclinepi.2004.03.002.CrossRefPubMed
24.
Gilmer T, Kronick R, Fishman P, Ganiats TG: The medicaid R-x model - pharmacy-based risk adjustment for public programs. Medical Care. 2001, 39: 1188-1202. 10.1097/00005650-200111000-00006.CrossRefPubMed
25.
Malone DC, Billups SJ, Valuck RJ, Carter BL: Development of a chronic disease indicator score using a veterans affairs medical center medication database. J Clin Epidemiol. 1999, 52: 551-557. 10.1016/S0895-4356(99)00029-3.CrossRefPubMed
26.
Fishman PA, Goodman MJ, Hornbrook MC, Meenan RT, Bachman DJ, Rosetti MCO: Risk adjustment using automated ambulatory pharmacy data - the RxRisk model. Medical Care. 2003, 41: 84-99. 10.1097/00005650-200301000-00011.CrossRefPubMed
27.
28.
29.
Kuo RN, Dong YH, Liu JP, Chang CH, Shau WY, Lai MS: Predicting healthcare utilization using a pharmacy-based metric with the WHO’s anatomic therapeutic chemical algorithm. Medical Care. 2011, 49: 1031-1039. 10.1097/MLR.0b013e31822ebe11.CrossRefPubMed
30.
Fortin M, Stewart M, Poitras ME, Almirall J, Maddocks H: A systematic review of prevalence studies on multimorbidity: toward a more uniform methodology. Annals Family Med. 2012, 10: 142-151. 10.1370/afm.1337.CrossRef
31.
Taylor AW, Price K, Gill TK, Adams R, Pilkington R, Carrangis N, Shi ZM, Wilson D: Multimorbidity - not just an older person’s issue. Results from an Australian biomedical study (retracted article. See vol. 46, pg. 351, 2011). BMC Publ Health. 2010, 10:
32.
Mercer SW, Smith SM, Wyke S, O’Dowd T, Watt GCM: Multimorbidity in primary care: developing the research agenda. Fam Pract. 2009, 26: 79-80. 10.1093/fampra/cmp020.CrossRefPubMed
33.
Fortin M, Hudon C, Haggerty J, van den Akker M, Almirall J: Prevalence estimates of multimorbidity: a comparative study of two sources. BMC Heal Serv Res. 2010, 10:
34.
Huntley AL, Johnson R, Purdy S, Valderas JM, Salisbury C: Measures of multimorbidity and morbidity burden for Use in primary care and community settings: a systematic review and guide. Annals Family Med. 2012, 10: 134-141. 10.1370/afm.1363.CrossRef
35.
Diederichs C, Berger K, Bartels DB: The measurement of multiple chronic diseases-a systematic review on existing multimorbidity indices. J Gerontol Series a-Biol Sci Med Sci. 2011, 66: 301-311.CrossRef
36.
Ghali WA, Quan H, Brant R: Risk adjustment using administrative data - impact of a diagnosis-type indicator. J General Int Med. 2001, 16: 519-524. 10.1046/j.1525-1497.2001.016008519.x.CrossRef
37.
Wilchesky M, Tamblyn RM, Huang A: Validation of diagnostic codes within medical services claims. J Clin Epidemiol. 2004, 57: 131-141. 10.1016/S0895-4356(03)00246-4.CrossRefPubMed
38.
van den Akker M, Buntinx F, Metsemakers JFM, Knottnerus JA: Marginal impact of psychosocial factors on multimorbidity: results of an explorative nested case–control study. Soc Sci Med. 2000, 50: 1679-1693. 10.1016/S0277-9536(99)00408-6.CrossRefPubMed
39.
Winkleby MA, Jatulis DE, Frank E, Fortmann SP: Socioeconomic-status and health - How education, income, and occupation contribute to risk-factors for cardiovascular-disease. Am J Public Health. 1992, 82: 816-820. 10.2105/AJPH.82.6.816.PubMedCentralCrossRefPubMed
40.
Braveman PA, Cubbin C, Egerter S, Chideya S, Marchi KS, Metzler M, Posner S: Socioeconomic status in health research - one size does not fit all. Jama-J Am Med Assoc. 2005, 294: 2879-2888. 10.1001/jama.294.22.2879.CrossRef
41.
Demakakos P, Nazroo J, Breeze E, Marmot M: Socioeconomic status and health: the role of subjective social status. Soc Sci Med. 2008, 67: 330-340. 10.1016/j.socscimed.2008.03.038.CrossRefPubMed
42.
Marmot M, Friel S, Bell R, Houweling TAJ, Taylor S, Hlt CSD: Closing the gap in a generation: health equity through action on the social determinants of health. Lancet. 2008, 372: 1661-1669. 10.1016/S0140-6736(08)61690-6.CrossRefPubMed
Metadata
Title
The influence of socio-economic status and multimorbidity patterns on healthcare costs: a six-year follow-up under a universal healthcare system
Authors
Raymond N Kuo
Mei-Shu Lai
Publication date
01-12-2013
Publisher
BioMed Central
Published in
International Journal for Equity in Health / Issue 1/2013
Electronic ISSN: 1475-9276
DOI
https://doi.org/10.1186/1475-9276-12-69

Other articles of this Issue 1/2013

International Journal for Equity in Health 1/2013 Go to the issue

Research

Taking stock of Myanmar’s progress toward the health-related Millennium Development Goals: current roadblocks, paths ahead

Research

Redistributive effects of the National Health Insurance on physicians in Taiwan: a natural experiment time series study

Research

“Everyone just keeps their eyes closed and their fingers crossed”: Sexual health communication among black parents and children in Nova Scotia, Canada

Research

Development and trialling of a tool to support a systems approach to improve social determinants of health in rural and remote Australian communities: the healthy community assessment tool

Research

The effect of Self-Help Groups on access to maternal health services: evidence from rural India

Research

Literacy and healthcare-seeking among women with low educational attainment: analysis of cross-sectional data from the 2011 Nepal demographic and health survey